| 000 | 01764 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516222006.0 | ||
| 264 | 0 | _c20150417 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a2191-0162 | ||
| 024 | 7 |
_a10.1515/dmdi-2014-0009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerali, Zahra | |
| 245 | 0 | 0 |
_aThe pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect. _h[electronic resource] |
| 260 |
_bDrug metabolism and drug interactions _c2014 |
||
| 300 |
_a143-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xmetabolism |
| 650 | 0 | 4 |
_aAntiviral Agents _xmetabolism |
| 650 | 0 | 4 |
_aAspirin _xmetabolism |
| 650 | 0 | 4 |
_aBenzimidazoles _xmetabolism |
| 650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCarboxylesterase _xgenetics |
| 650 | 0 | 4 |
_aCarboxylic Ester Hydrolases _xchemistry |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xmetabolism |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aDabigatran |
| 650 | 0 | 4 |
_aFactor Xa Inhibitors _xmetabolism |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazolidines _xmetabolism |
| 650 | 0 | 4 | _aIrinotecan |
| 650 | 0 | 4 |
_aIsoenzymes _xchemistry |
| 650 | 0 | 4 |
_aMethylphenidate _xmetabolism |
| 650 | 0 | 4 |
_aOseltamivir _xmetabolism |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xmetabolism |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aPyridines _xmetabolism |
| 650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
| 700 | 1 | _aRoss, Stephanie | |
| 700 | 1 | _aParé, Guillaume | |
| 773 | 0 |
_tDrug metabolism and drug interactions _gvol. 29 _gno. 3 _gp. 143-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/dmdi-2014-0009 _zAvailable from publisher's website |
| 999 |
_c23975183 _d23975183 |
||